2020 Partners

Draper logo

Draper

Expertise Partner

Draper is an independent, not-for-profit corporation, which means its primary commitment is to the success of clients’ missions rather than to shareholders. For either government or private sector customers, Draper leverages its deep experience and innovative thinking to be an effective engineering research and development partner, designing solutions or objectively evaluating the ideas or products of others. Draper will partner with other organizations — from large for-profit prime contractors, to government agencies, to university researchers — in a variety of capacities. Services Draper provides range from concept development through delivered solution and lifecycle support. Draper’s multidisciplinary teams of engineers and scientists can deliver useful solutions to even the most critical problems.

www.draper.com

Stemonix logo

StemoniX

Expertise Partner

Our mission is to accelerate the discovery of new medicines with physiologically-relevant, structured human cells in high density plates. We develop and manufacture human induced pluripotent stem cell-derived cardiac and neuronal platforms for high throughput drug toxicity and efficacy screening. Predictive, accurate, and consistent, our human models enable scientists to economically conduct research in a simplified workflow. StemoniX microHeart® products provide researchers with structurally aligned cardiac cells resembling native human heart tissue with accelerated features of cell maturity, essential in predicting drug toxicity and efficacy. We also collaborate with drug discovery organizations to operationalize their human cells for drug screening.

www.stemonix.com

TARA Biosystems logo
Nanosurface Biomedical

TARA Biosystems

Spotlight Partner

TARA Biosystems, Inc. provides predictive, in vitro human cardiac tissue models for use in drug discovery and safety assessment. TARA Biosystems offers a high fidelity solution that is based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels and provides direct measures of cardiac functionality, including contractile force. The TARA solution will provide safety data earlier in the development cycle and a high fidelity discovery model.

www.tarabiosystems.com

NanoSurface Biomedical

Spotlight Partner

NanoSurface Biomedical is accelerating drug development with humanrelevant stem cell-based assays. At NanoSurface, we believe that cells in the dish should resemble cells in the body. We use bioengineering techniques to enhance nearly all endpoint assays in an instrument- and cell-agnostic manner. Our biomimetic nanopatterning technology imitates the geometry of the native extracellular matrix and drives the organization, migration, proliferation, and phenotypic development and maturity of many cell types. The NanoSurface Car(ina) platform uses extracellular matrix cues to drive the maturity of iPSC-derived cardiomyocytes, making these cell models more representative of human biology. The NanoSurface Cytostretcher family of cell stretching instruments enables researchers to apply programmable stretch routines to flexible nanopatterned culture substrates, either in the incubator or on an optical microscope stage, to explore the effects of mechanical stimulation on the maturation of cell and tissue cultures.

The NanoSurface eCyte 6 is an electrical stimulation system for long-term electrical stimulation and pacing of excitable cells in vitro. Our suite of technologies is driven by our goal to greatly improve the predictive power of cell based assays.

www.nanosurfacebio.com

sdvjbhv

Obatala Sciences, Inc

Spotlight Partner

Obatala Sciences, Inc is a biotechnology company that offers brain power and research tools to advance the fields of obesity, diabetes, related metabolic disorders and cancers, and regenerative medicine. Our mission is to drive diversity in research and impact the future of regenerative medicine. To advance this mission, we manufacture adult stem/stromal cells, unique 3D cell culture tools, and we are progressing an FDA-approved protocol for testing a stem cell based therapy for wound healing applications in humans.

www.obatalasciences.com